Nav: Home

William Small, Jr., M.D., named Loyola Senior Scientist of the Year

November 28, 2016

MAYWOOD, IL - William Small, Jr., MD, FACRO, FACR, FASTRO, chair of the department of radiation oncology, has been named Loyola University Chicago Stritch School of Medicine's Senior Scientist of the Year.

The award is based on scholarly productivity, service to the institution and community, professional society activities, research funding, mentoring and peer-review activities for both scientific journals and external sponsors of research funding.

Dr. Small received the award November 3 during the 37th annual St. Albert's Day, which celebrates Loyola's commitment to research. Lara Dugas, PhD, MPH, assistant professor, department of public health sciences, was named Junior Scientist of the Year.

Dr. Small is a fellow of the American College of Radiation Oncology, American College of Radiology and American Society for Radiation Oncology. He is former president of the Council of Affiliated Regional Radiation Oncology Societies and the Chicago Radiological Society. He is immediate past chair of the Gynecological Cancer Intergroup.

Dr. Small has been lead researcher in multiple national and international clinical trials. He has written more than 190 publications, 25 invited book chapters and six books, including textbooks on toxicity and combining targeted biological agents with radiation.

Dr. Small has published in many leading journals and is a member of multiple editorial boards, including Advances in Radiation Oncology and Brachytherapy. Dr. Small also has helped bring state-of-the-art cancer clinical trials to low- and middle-income countries.
-end-


Loyola University Health System

Related Radiation Articles:

What membrane can do in dealing with radiation
USTC recently found that polymethylmethacrylate (PMMA) and polyvinyl chloride (PVC) can release acidic substance under γ radiation, whose amount is proportional to the radiation intensity.
First measurements of radiation levels on the moon
In the current issue (25 September) of the prestigious journal Science Advances, Chinese and German scientists report for the first time on time-resolved measurements of the radiation on the moon.
New biomaterial could shield against harmful radiation
Northwestern University researchers have synthesized a new form of melanin enriched with selenium.
A new way to monitor cancer radiation therapy doses
More than half of all cancer patients undergo radiation therapy and the dose is critical.
Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
Oncotarget Volume 11, Issue 4: In this study, locally advanced head and neck cancer patients undergoing definitive chemoradiation were randomly allocated to weekly cisplatin - radiation {CRT arm} or nimotuzumab -weekly cisplatin -radiation {NCRT arm}.
Breaking up amino acids with radiation
A new experimental and theoretical study published in EPJ D has shown how the ions formed when electrons collide with one amino acid, glutamine, differ according to the energy of the colliding electrons.
Radiation breaks connections in the brain
One of the potentially life-altering side effects that patients experience after cranial radiotherapy for brain cancer is cognitive impairment.
Fragmenting ions and radiation sensitizers
The anti-cancer drug 5-fluorouracil (5FU) acts as a radiosensitizer: it is rapidly taken up into the DNA of cancer cells, making the cells more sensitive to radiotherapy.
'Seeing the light' behind radiation therapy
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime.
Radiation contamination at a crematorium
Radioactive compounds known as radiopharmaceuticals are used in nuclear medicine procedures to diagnose and treat disease.
More Radiation News and Radiation Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Warped Reality
False information on the internet makes it harder and harder to know what's true, and the consequences have been devastating. This hour, TED speakers explore ideas around technology and deception. Guests include law professor Danielle Citron, journalist Andrew Marantz, and computer scientist Joy Buolamwini.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.